Patents by Inventor Paul J. Edwards

Paul J. Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160125546
    Abstract: According to some embodiments, data may be received indicative of a plurality of insurance claims. A risk transfer opportunity platform processor may, based on the received data, identify an insurance claim as being associated with a potential risk transfer opportunity. For the identified insurance claim, the risk transfer opportunity platform processor may automatically arrange for a potential risk transfer user interface to be displayed to a claim handler and may receive, via the potential risk transfer user interface, recovery details from the claim handler, including an overall total damage value and a high and low risk transfer value. A summary report may then be automatically generated for a plurality of insurance claims based in part on the recovery details received from the claim handler, and an indication of the summary report may be transmitted.
    Type: Application
    Filed: June 22, 2015
    Publication date: May 5, 2016
    Inventors: Daniel Lee Bostic, Paul J. Edwards, Andrew J. Reed, Michael Adam Scott, Keren Shemesh
  • Publication number: 20160110818
    Abstract: According to some embodiments, data is received indicative of a plurality of insurance claims. It may then be automatically determined that a first insurance claim is associated with a first type of insurance and that a second insurance claim is associated with a second type of insurance different from the first type of insurance. The received data associated with the first insurance claim may be analyzed, in accordance with first fraud detection logic, to determine a first questionable loss status appropriate for the first insurance claim. Similarly, the received data associated with the second insurance claim may be analyzed, in accordance with second fraud detection logic different from the first fraud detection logic, to determine a second questionable loss status appropriate for the second insurance claim. Indications of the first and second questionable loss statuses may then be transmitted (e.g., to a claim handler or a special investigation unit platform).
    Type: Application
    Filed: April 27, 2015
    Publication date: April 21, 2016
    Inventors: Keren Shemesh, Paul J. Edwards, Geoffrey P. Hayden, Andrew D. Preece, Odie Waters, II
  • Publication number: 20160071217
    Abstract: According to some embodiments, data may be received indicative of a plurality of insurance claims along with an indication of an appropriate claim segment classification for each insurance claim. A first claim handler may then be automatically selected for a first insurance claim based at least in part on: (i) a first segment classification associated with the first insurance claim, (ii) numbers of other insurance claims currently assigned to claim handlers, and (iii) load factors associated with claim handlers. An indication of the selected first claim handler may then be transmitted.
    Type: Application
    Filed: October 31, 2014
    Publication date: March 10, 2016
    Inventors: Paul J. Edwards, Keren Shemesh
  • Publication number: 20160071218
    Abstract: According to some embodiments, data is received indicative of a plurality of insurance claims. It may then be automatically determined that a first insurance claim is associated with a first type of insurance and that a second insurance claim is associated with a second type of insurance. The received data associated with the first insurance claim may be analyzed in accordance with first segmentation logic to determine a first segment classification appropriate for the first insurance claim. Similarly, the received data associated with the second insurance claim may be automatically analyzed in accordance with second segmentation logic to determine a second segment classification appropriate for the second insurance claim. Indications of the first and second segment classifications may then be transmitted (e.g., to a load balancing and assignment engine that automatically selects claim handlers for insurance claims).
    Type: Application
    Filed: October 31, 2014
    Publication date: March 10, 2016
    Inventors: Cory R. Blakeman, Paul J. Edwards, Keren Shemesh
  • Publication number: 20130339061
    Abstract: According to some embodiments, an indication of a pay period frequency may be received from an insured along with an indication of an initial pay period begin date. A series of pay period begin date and pay period end date fields may then be automatically populated based on the pay period frequency and initial pay period begin date. Wage values associated with a plurality of the pay period begin date and pay period end date fields may be received from the insured, and an electronic wage statement file may be generated based on the received wage values.
    Type: Application
    Filed: June 15, 2012
    Publication date: December 19, 2013
    Inventor: Paul J. Edwards
  • Patent number: 8461180
    Abstract: Compounds of formula (I): wherein c, X, Y, R2, R4 and R5 are defined herein, are useful as inhibitors of HIV replication.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: June 11, 2013
    Assignee: Gilead Sciences, Inc.
    Inventors: Youla S. Tsantrizos, Murray D. Bailey, Punit-Kumar Bhardwaj, Christian Brochu, Paul J. Edwards, Lee Fader, Araz Jakalian, Stephen Kawai, Mathieu Parisien, Marc-Andre Poupart, Bruno Simoneau
  • Patent number: 8349839
    Abstract: Compounds of formula (I): wherein R1, R2, A1, A2, A3, A4, X and Y are as defined herein, are useful as inhibitors of HIV replication.
    Type: Grant
    Filed: April 8, 2010
    Date of Patent: January 8, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Claudio Sturino, Patrick Deroy, Martin Duplessis, Paul J. Edwards, Anne-Marie Faucher, Teddy Halmos, Clint James, Jean-Eric Lacoste, Eric Malenfant, Joannie Minville, Louis Morency, Sebastien Morin, Martin Tremblay, Christiane Yoakim
  • Patent number: 8242140
    Abstract: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Grant
    Filed: July 31, 2008
    Date of Patent: August 14, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Pierre L. Beaulieu, Paul J. Edwards, Martin Poirier, Jean Rancourt, Timothy A. Stammers
  • Publication number: 20110230465
    Abstract: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Application
    Filed: September 16, 2010
    Publication date: September 22, 2011
    Applicant: BOEHRINGER INGLEHEIM INTERNATIONAL GMBH
    Inventors: Timothy STAMMERS, Xavier BARBEAU, Pierre BEAULIEU, Megan BERTRAND-LAPERLE, Christian BROCHU, Paul J. EDWARDS, Pasquale FORGIONE, Cédrickx GODBOUT, Oliver HUCKE, Marc-André JOLY, Serge LANDRY, Olivier LEPAGE, Julie NAUD, Marc PESANT, Martin POIRIER, Maude POIRIER, Bounkham THAVONEKHAM
  • Publication number: 20110118249
    Abstract: Compounds of formula (I): wherein c, X, Y, R2, R4 and R5 are defined herein, are useful as inhibitors of HIV replication.
    Type: Application
    Filed: November 13, 2008
    Publication date: May 19, 2011
    Applicant: BOEHRINGER INGLEHEIM INTERNATIONAL GMBH
    Inventors: Youla S. Tsantrizos, Murray D. Bailey, Punit-Kumar Bhardwaj, Christian Brochu, Paul J. Edwards, Lee Fader, Araz Jakalian, Stephen Kawai, Mathieu Parisien, Marc-Andre Poupart, Bruno Simoneau
  • Publication number: 20100261714
    Abstract: Compounds of formula (I): wherein R1, R2, A1, A2, A3, A4, X and Y are as defined herein, are useful as inhibitors of HIV replication.
    Type: Application
    Filed: April 8, 2010
    Publication date: October 14, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Claudio STURINO, Patrick DEROY, Martin DUPLESSIS, Paul J. EDWARDS, Anne-Marie FAUCHER, Teddy HALMOS, Clint JAMES, Jean-Eric LACOSTE, Eric MALENFANT, Joannie MINVILLE, Louis MORENCY, Sebastien MORIN, Martin TREMBLAY, Christiane YOAKIM
  • Publication number: 20100190779
    Abstract: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Application
    Filed: July 31, 2008
    Publication date: July 29, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Pierre L. Beaulieu, Paul J. Edwards, Martin Poirier, Jean Rancourt, Timothy A. Stammers